Soligenix, Inc. (SNGX)
Nasdaq: SNGX · Pharmaceutical Preparations · Princeton, NJ · filing with the SEC since 1995
Who owns Soligenix, Inc.
As filed with the SECHolders of 5% or more
1
Michael Liu holds 5.7% of Common Stock, par value $.001 per share, as its SCHEDULE 13G filed Jun 25, 2026 says.
Directors and officers
8
report now, of 14 people on the record since 2006. Their holdings as a group are not read here.
Institutions as a whole
n/a
The record does not read the share held by managers that file Form 13F, so none is printed and no split of the rest is estimated. What it holds is the 1 named at left.
Holders of 5% or moreshare of the class, as filed
Michael Liu
SCHEDULE 13G · filed Jun 25, 2026 · Common Stock, par value $.001 per share
Armistice Capital, LLC
SCHEDULE 13G/A · filed Feb 17, 2026 · Common Stock, par value $.001 per share · reported falling below 5%, from 6.72% in Nov 14, 2025
Mitchell P. Kopin
SCHEDULE 13G · filed Oct 1, 2025 · Common Stock, par value $0.001 per share · reported falling below 5%
What SNGX reports owning in othersstakes of 5% or more, and other ties
6 subsidiaries in 4 countries, from the list filed with the 10-K filed Mar 31, 2026.
Insider tradesForm 4
0sales
0purchases
0sales on a scheduled plan
0people selling
$0sold, in dollars
$0bought, in dollars
Open-market trades on Form 4 from Oct 13, 2025 to Oct 13, 2026. A scheduled plan is a selling program set in advance under SEC rule 10b5-1. The trades are listed as filed and do not feed the grade.
By calendar yearSoldBought
2025 runs to Oct 13, 2026. Dollars as filed, summed by the transaction date.
People who traded in the window
No one on the roster filed an open-market trade in the window.